Cocrystal Pharma (COCP) Other Non Operating Income (2012 - 2026)
Cocrystal Pharma (COCP) posted Other Non Operating Income of $35000.0 for Q1 2026, up 337.5% sequentially from $8000.0 in Q4 2025, and up 1066.67% YoY from $3000.0 in Q1 2025.
Cocrystal Pharma (COCP) Other Non Operating Income (2012 - 2026) Analysis & Trends
Cocrystal Pharma has reported Other Non Operating Income for 14 years, with the latest figure at $35000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 1066.67% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86000.0 (up 160.56% YoY) and the FY2025 annual result came in at $54000.0, up 133.13% from the prior year.
- Other Non Operating Income climbed to $35000.0 in Q1 2026 per COCP's latest filing, from $8000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $35000.0 in Q1 2026 and troughed at -$91000.0 in Q4 2024.
- A 5-year average of -$9875.0 and a median of -$3000.0 in 2022 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income plunged 1400.0% in 2022, then surged 3400.0% in 2023.
- Over 5 years, Other Non Operating Income stood at -$5000.0 in 2022, then soared by 540.0% to $22000.0 in 2023, then plunged by 513.64% to -$91000.0 in 2024, then soared by 108.79% to $8000.0 in 2025, then jumped by 337.5% to $35000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $35000.0, $8000.0, and $18000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | -91,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -46,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | -42,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | -78,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 9,000.00 |